These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 15067374

  • 1. Osteosarcoma and chondrosarcoma as targets for virus vectors and herpes simplex virus thymidine kinase/ganciclovir gene therapy.
    Ketola A, Määttä AM, Pasanen T, Tulimäki K, Wahlfors J.
    Int J Mol Med; 2004 May; 13(5):705-10. PubMed ID: 15067374
    [Abstract] [Full Text] [Related]

  • 2. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy.
    Loimas S, Toppinen MR, Visakorpi T, Jänne J, Wahlfors J.
    Cancer Gene Ther; 2001 Feb; 8(2):137-44. PubMed ID: 11263529
    [Abstract] [Full Text] [Related]

  • 3. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
    Yang J, Liu TJ, Lu Y.
    Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 5. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM, Tenhunen A, Pasanen T, Meriläinen O, Pellinen R, Mäkinen K, Alhava E, Wahlfors J.
    Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
    [Abstract] [Full Text] [Related]

  • 6. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
    Burrows FJ, Gore M, Smiley WR, Kanemitsu MY, Jolly DJ, Read SB, Nicholas T, Kruse CA.
    Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
    [Abstract] [Full Text] [Related]

  • 7. Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy.
    Rautsi O, Lehmusvaara S, Ketola A, Määttä AM, Wahlfors J, Pellinen R.
    Cancer Gene Ther; 2008 May; 15(5):303-14. PubMed ID: 18309353
    [Abstract] [Full Text] [Related]

  • 8. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
    Moriuchi S, Krisky DM, Marconi PC, Tamura M, Shimizu K, Yoshimine T, Cohen JB, Glorioso JC.
    Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
    [Abstract] [Full Text] [Related]

  • 9. A cell type-specific and gap junction-independent mechanism for the herpes simplex virus-1 thymidine kinase gene/ganciclovir-mediated bystander effect.
    Princen F, Robe P, Lechanteur C, Mesnil M, Rigo JM, Gielen J, Merville MP, Bours V.
    Clin Cancer Res; 1999 Nov; 5(11):3639-44. PubMed ID: 10589781
    [Abstract] [Full Text] [Related]

  • 10. Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.
    Hasegawa Y, Nishiyama Y, Imaizumi K, Ono N, Kinoshita T, Hatano S, Saito H, Shimokata K.
    Cancer Gene Ther; 2000 Apr; 7(4):557-62. PubMed ID: 10811473
    [Abstract] [Full Text] [Related]

  • 11. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S, Steffens S, Fischer U, Tlolko A, Rainov NG, Kramm CM.
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [Abstract] [Full Text] [Related]

  • 12. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 13. Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-alpha and herpes simplex virus thymidine kinase.
    Moriuchi S, Oligino T, Krisky D, Marconi P, Fink D, Cohen J, Glorioso JC.
    Cancer Res; 1998 Dec 15; 58(24):5731-7. PubMed ID: 9865731
    [Abstract] [Full Text] [Related]

  • 14. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 15; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 15. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
    Wiewrodt R, Amin K, Kiefer M, Jovanovic VP, Kapoor V, Force S, Chang M, Lanuti M, Black ME, Kaiser LR, Albelda SM.
    Cancer Gene Ther; 2003 May 15; 10(5):353-64. PubMed ID: 12719705
    [Abstract] [Full Text] [Related]

  • 16. Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer.
    Kagaya T, Nakamoto Y, Sakai Y, Tsuchiyama T, Yagita H, Mukaida N, Kaneko S.
    Cancer Gene Ther; 2006 Apr 15; 13(4):357-66. PubMed ID: 16224495
    [Abstract] [Full Text] [Related]

  • 17. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis.
    Agard C, Ligeza C, Dupas B, Izembart A, El Kouri C, Moullier P, Ferry N.
    Cancer Gene Ther; 2001 Feb 15; 8(2):128-36. PubMed ID: 11263528
    [Abstract] [Full Text] [Related]

  • 18. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model.
    Tyynelä K, Sandmair AM, Turunen M, Vanninen R, Vainio P, Kauppinen R, Johansson R, Vapalahti M, Ylä-Herttuala S.
    Cancer Gene Ther; 2002 Nov 15; 9(11):917-24. PubMed ID: 12386830
    [Abstract] [Full Text] [Related]

  • 19. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines.
    Balzarini J, Ostrowski T, Goslinski T, De Clercq E, Golankiewicz B.
    Gene Ther; 2002 Sep 15; 9(17):1173-82. PubMed ID: 12170381
    [Abstract] [Full Text] [Related]

  • 20. [Studies on herpes simplex virus thymidine kinase gene and GCV system for treatment of human bladder carcinoma].
    He J, Chen Y, Li H, Lu Y, Yan Y, Tan X.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun 15; 21(3):428-32. PubMed ID: 15250149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.